Sturm Ruger& Co. Inc. (RGR) Drops 5.43% on January 11

Equities Staff  |

Sturm Ruger& Co. Inc. (RGR) was one of the Russell 2000's biggest losers for Monday January 11 as the stock slid 5.43% to $55.07, a loss of $-3.1617 per share. Starting at an opening price of $58.30 a share, the stock traded between $54.96 and $58.64 over the course of the trading day. Volume was 416,622 shares over 3,411 trades, against an average daily volume of 205,644 shares and a total float of 18.7 million.

The losses send Sturm Ruger& Co. Inc. down to a market cap of $1.03 billion. In the last year, Sturm Ruger& Co. Inc. has traded between $66.93 and $36.00, and its 50-day SMA is currently $55.84 and 200-day SMA is $56.39.

The stock has a P/E Ratio of 36.4.

Sturm Ruger & Co Inc is engaged in the design, manufacture, and sale of firearms to domestic customers. The Company also manufactures and sells investment castings made from steel alloys for internal use in the firearms segment.

Sturm Ruger& Co. Inc. is based out of Southport, CT and has some 2,073 employees. Its CEO is Michael O. Fifer.

For a complete fundamental analysis analysis of Sturm Ruger& Co. Inc., check out’s Stock Valuation Analysis report for RGR. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Level Headed at World Crypto Con - Steve Beauregard CRO Steve Beauregard joins Jack Brewer at World Crypto Con.

Emerging Growth

Q BioMed Inc

Q BioMed Inc is a biomedical acceleration and development company. The company is a biomedical acceleration and development company focused on licensing, acquiring and providing strategic resources to life sciences…